You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
RISPERDAL is indicated for the treatment of schizophrenia and related psychoses. RISPERDAL is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. RISPERDAL is also indicated for the treatment of behavioural disturbances in dementia. RISPERDAL is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see Clinical Trials for maintenance data). RISPERDAL is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see Clinical Trials).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
RISPERDAL is indicated for the treatment of schizophrenia and related psychoses. RISPERDAL is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. RISPERDAL is also indicated for the treatment of behavioural disturbances in dementia. RISPERDAL is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see Clinical Trials for maintenance data). RISPERDAL is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see Clinical Trials).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
RISPERDAL is indicated for the treatment of schizophrenia and related psychoses. RISPERDAL is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. RISPERDAL is also indicated for the treatment of behavioural disturbances in dementia. RISPERDAL is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see Clinical Trials for maintenance data). RISPERDAL is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see Clinical Trials).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
RISPERDAL is indicated for the treatment of schizophrenia and related psychoses. RISPERDAL is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. RISPERDAL is also indicated for the treatment of behavioural disturbances in dementia. RISPERDAL is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see Clinical Trials for maintenance data). RISPERDAL is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see Clinical Trials).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
RISPERDAL is indicated for the treatment of schizophrenia and related psychoses. RISPERDAL is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. RISPERDAL is also indicated for the treatment of behavioural disturbances in dementia. RISPERDAL is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see Clinical Trials for maintenance data). RISPERDAL is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see Clinical Trials).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
RISPERDAL is indicated for the treatment of schizophrenia and related psychoses. RISPERDAL is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. RISPERDAL is also indicated for the treatment of behavioural disturbances in dementia. RISPERDAL is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see Clinical Trials for maintenance data). RISPERDAL is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see Clinical Trials).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
RISPERDAL is indicated for the treatment of schizophrenia and related psychoses. RISPERDAL is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. RISPERDAL is also indicated for the treatment of behavioural disturbances in dementia. RISPERDAL is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see Clinical Trials for maintenance data). RISPERDAL is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see Clinical Trials).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
RISPERDAL is indicated for the treatment of schizophrenia and related psychoses. RISPERDAL is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. RISPERDAL is also indicated for the treatment of behavioural disturbances in dementia. RISPERDAL is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see Clinical Trials for maintenance data). RISPERDAL is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see Clinical Trials).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
